nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—Epirubicin—pancreatic cancer	0.0764	0.0883	CbGbCtD
Amprenavir—ABCC1—Irinotecan—pancreatic cancer	0.0743	0.0859	CbGbCtD
Amprenavir—ABCC1—Docetaxel—pancreatic cancer	0.0545	0.0629	CbGbCtD
Amprenavir—CYP2B6—Tamoxifen—pancreatic cancer	0.0455	0.0526	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—pancreatic cancer	0.0406	0.0469	CbGbCtD
Amprenavir—CYP3A5—Tamoxifen—pancreatic cancer	0.0359	0.0415	CbGbCtD
Amprenavir—CYP2B6—Irinotecan—pancreatic cancer	0.035	0.0404	CbGbCtD
Amprenavir—CYP2C8—Tamoxifen—pancreatic cancer	0.0345	0.0399	CbGbCtD
Amprenavir—CYP3A5—Erlotinib—pancreatic cancer	0.0305	0.0353	CbGbCtD
Amprenavir—CYP2C8—Erlotinib—pancreatic cancer	0.0293	0.0339	CbGbCtD
Amprenavir—CYP2C19—Tamoxifen—pancreatic cancer	0.0289	0.0334	CbGbCtD
Amprenavir—CYP3A5—Irinotecan—pancreatic cancer	0.0275	0.0318	CbGbCtD
Amprenavir—CYP2C8—Fluorouracil—pancreatic cancer	0.0254	0.0294	CbGbCtD
Amprenavir—CYP2C9—Tamoxifen—pancreatic cancer	0.0241	0.0278	CbGbCtD
Amprenavir—ABCB1—Tamoxifen—pancreatic cancer	0.0233	0.027	CbGbCtD
Amprenavir—CYP2D6—Tamoxifen—pancreatic cancer	0.022	0.0254	CbGbCtD
Amprenavir—CYP3A5—Docetaxel—pancreatic cancer	0.0202	0.0233	CbGbCtD
Amprenavir—ABCB1—Gemcitabine—pancreatic cancer	0.0201	0.0232	CbGbCtD
Amprenavir—CYP3A5—Sunitinib—pancreatic cancer	0.0201	0.0232	CbGbCtD
Amprenavir—ABCB1—Erlotinib—pancreatic cancer	0.0199	0.0229	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—pancreatic cancer	0.0191	0.0221	CbGbCtD
Amprenavir—CYP2D6—Erlotinib—pancreatic cancer	0.0187	0.0216	CbGbCtD
Amprenavir—ABCB1—Irinotecan—pancreatic cancer	0.0179	0.0207	CbGbCtD
Amprenavir—CYP2C9—Fluorouracil—pancreatic cancer	0.0177	0.0205	CbGbCtD
Amprenavir—CYP3A4—Tamoxifen—pancreatic cancer	0.014	0.0162	CbGbCtD
Amprenavir—ABCB1—Docetaxel—pancreatic cancer	0.0131	0.0152	CbGbCtD
Amprenavir—ABCB1—Sunitinib—pancreatic cancer	0.0131	0.0151	CbGbCtD
Amprenavir—CYP3A4—Erlotinib—pancreatic cancer	0.0119	0.0137	CbGbCtD
Amprenavir—CYP3A4—Irinotecan—pancreatic cancer	0.0107	0.0124	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—pancreatic cancer	0.00979	0.0113	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—pancreatic cancer	0.00923	0.0107	CbGbCtD
Amprenavir—CYP3A4—Docetaxel—pancreatic cancer	0.00787	0.0091	CbGbCtD
Amprenavir—CYP3A4—Sunitinib—pancreatic cancer	0.00784	0.00906	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—pancreatic cancer	0.00587	0.00678	CbGbCtD
Amprenavir—Erythema multiforme—Tamoxifen—pancreatic cancer	0.000713	0.00529	CcSEcCtD
Amprenavir—Acute coronary syndrome—Sunitinib—pancreatic cancer	0.00071	0.00526	CcSEcCtD
Amprenavir—Erythema multiforme—Erlotinib—pancreatic cancer	0.000706	0.00524	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Irinotecan—pancreatic cancer	0.000693	0.00514	CcSEcCtD
Amprenavir—Liver function test abnormal—Gemcitabine—pancreatic cancer	0.000692	0.00513	CcSEcCtD
Amprenavir—Hepatobiliary disease—Sunitinib—pancreatic cancer	0.000681	0.00505	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Gemcitabine—pancreatic cancer	0.000675	0.00501	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Gemcitabine—pancreatic cancer	0.000661	0.0049	CcSEcCtD
Amprenavir—Mental disorder—Erlotinib—pancreatic cancer	0.000654	0.00485	CcSEcCtD
Amprenavir—Malnutrition—Erlotinib—pancreatic cancer	0.00065	0.00482	CcSEcCtD
Amprenavir—Flatulence—Erlotinib—pancreatic cancer	0.00064	0.00475	CcSEcCtD
Amprenavir—Connective tissue disorder—Sunitinib—pancreatic cancer	0.000635	0.00471	CcSEcCtD
Amprenavir—Neutropenia—Irinotecan—pancreatic cancer	0.000622	0.00461	CcSEcCtD
Amprenavir—Erythema multiforme—Sunitinib—pancreatic cancer	0.000611	0.00453	CcSEcCtD
Amprenavir—Neutropenia—Gemcitabine—pancreatic cancer	0.000606	0.00449	CcSEcCtD
Amprenavir—Angioedema—Tamoxifen—pancreatic cancer	0.0006	0.00445	CcSEcCtD
Amprenavir—Cardiac disorder—Sunitinib—pancreatic cancer	0.0006	0.00445	CcSEcCtD
Amprenavir—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.000584	0.00434	CcSEcCtD
Amprenavir—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000584	0.00434	CcSEcCtD
Amprenavir—Myocardial infarction—Irinotecan—pancreatic cancer	0.000581	0.00431	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000573	0.00425	CcSEcCtD
Amprenavir—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.000569	0.00422	CcSEcCtD
Amprenavir—Myocardial infarction—Gemcitabine—pancreatic cancer	0.000566	0.0042	CcSEcCtD
Amprenavir—Mental disorder—Sunitinib—pancreatic cancer	0.000566	0.0042	CcSEcCtD
Amprenavir—Malnutrition—Sunitinib—pancreatic cancer	0.000563	0.00417	CcSEcCtD
Amprenavir—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.00056	0.00415	CcSEcCtD
Amprenavir—Myalgia—Tamoxifen—pancreatic cancer	0.000559	0.00415	CcSEcCtD
Amprenavir—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000557	0.00413	CcSEcCtD
Amprenavir—Flatulence—Sunitinib—pancreatic cancer	0.000554	0.00411	CcSEcCtD
Amprenavir—Myalgia—Erlotinib—pancreatic cancer	0.000553	0.0041	CcSEcCtD
Amprenavir—Discomfort—Tamoxifen—pancreatic cancer	0.000552	0.0041	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.000549	0.00408	CcSEcCtD
Amprenavir—Hepatobiliary disease—Gemcitabine—pancreatic cancer	0.000546	0.00405	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Epirubicin—pancreatic cancer	0.000543	0.00403	CcSEcCtD
Amprenavir—Connective tissue disorder—Irinotecan—pancreatic cancer	0.000523	0.00388	CcSEcCtD
Amprenavir—Nervous system disorder—Erlotinib—pancreatic cancer	0.00052	0.00386	CcSEcCtD
Amprenavir—Skin disorder—Erlotinib—pancreatic cancer	0.000515	0.00382	CcSEcCtD
Amprenavir—Angioedema—Sunitinib—pancreatic cancer	0.000514	0.00381	CcSEcCtD
Amprenavir—Anorexia—Tamoxifen—pancreatic cancer	0.000511	0.00379	CcSEcCtD
Amprenavir—Connective tissue disorder—Gemcitabine—pancreatic cancer	0.00051	0.00378	CcSEcCtD
Amprenavir—Inflammation—Epirubicin—pancreatic cancer	0.000509	0.00378	CcSEcCtD
Amprenavir—Anorexia—Erlotinib—pancreatic cancer	0.000506	0.00375	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Doxorubicin—pancreatic cancer	0.000503	0.00373	CcSEcCtD
Amprenavir—Cardiac disorder—Irinotecan—pancreatic cancer	0.000494	0.00366	CcSEcCtD
Amprenavir—Liver function test abnormal—Docetaxel—pancreatic cancer	0.000491	0.00364	CcSEcCtD
Amprenavir—Erythema multiforme—Gemcitabine—pancreatic cancer	0.00049	0.00364	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000488	0.00362	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000483	0.00358	CcSEcCtD
Amprenavir—Paraesthesia—Tamoxifen—pancreatic cancer	0.000481	0.00357	CcSEcCtD
Amprenavir—Cardiac disorder—Gemcitabine—pancreatic cancer	0.000481	0.00357	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Docetaxel—pancreatic cancer	0.000479	0.00355	CcSEcCtD
Amprenavir—Myalgia—Sunitinib—pancreatic cancer	0.000479	0.00355	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.000476	0.00353	CcSEcCtD
Amprenavir—Inflammation—Doxorubicin—pancreatic cancer	0.000471	0.0035	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Docetaxel—pancreatic cancer	0.000469	0.00348	CcSEcCtD
Amprenavir—Decreased appetite—Tamoxifen—pancreatic cancer	0.000466	0.00346	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000463	0.00343	CcSEcCtD
Amprenavir—Fatigue—Tamoxifen—pancreatic cancer	0.000462	0.00343	CcSEcCtD
Amprenavir—Decreased appetite—Erlotinib—pancreatic cancer	0.000461	0.00342	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000458	0.0034	CcSEcCtD
Amprenavir—Fatigue—Erlotinib—pancreatic cancer	0.000457	0.00339	CcSEcCtD
Amprenavir—Flatulence—Irinotecan—pancreatic cancer	0.000457	0.00339	CcSEcCtD
Amprenavir—Nervous system disorder—Sunitinib—pancreatic cancer	0.00045	0.00334	CcSEcCtD
Amprenavir—Skin disorder—Sunitinib—pancreatic cancer	0.000446	0.00331	CcSEcCtD
Amprenavir—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000438	0.00325	CcSEcCtD
Amprenavir—Anorexia—Sunitinib—pancreatic cancer	0.000438	0.00325	CcSEcCtD
Amprenavir—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000434	0.00322	CcSEcCtD
Amprenavir—Neutropenia—Docetaxel—pancreatic cancer	0.00043	0.00319	CcSEcCtD
Amprenavir—Abdominal pain—Tamoxifen—pancreatic cancer	0.000424	0.00314	CcSEcCtD
Amprenavir—Abdominal pain—Erlotinib—pancreatic cancer	0.000419	0.00311	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000418	0.0031	CcSEcCtD
Amprenavir—Diabetes mellitus—Epirubicin—pancreatic cancer	0.000412	0.00306	CcSEcCtD
Amprenavir—Paraesthesia—Sunitinib—pancreatic cancer	0.000412	0.00306	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000406	0.00301	CcSEcCtD
Amprenavir—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000404	0.003	CcSEcCtD
Amprenavir—Myocardial infarction—Docetaxel—pancreatic cancer	0.000402	0.00298	CcSEcCtD
Amprenavir—Decreased appetite—Sunitinib—pancreatic cancer	0.000399	0.00296	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000396	0.00294	CcSEcCtD
Amprenavir—Fatigue—Sunitinib—pancreatic cancer	0.000396	0.00294	CcSEcCtD
Amprenavir—Discomfort—Irinotecan—pancreatic cancer	0.00039	0.00289	CcSEcCtD
Amprenavir—Hepatobiliary disease—Docetaxel—pancreatic cancer	0.000388	0.00288	CcSEcCtD
Amprenavir—Asthenia—Tamoxifen—pancreatic cancer	0.000385	0.00285	CcSEcCtD
Amprenavir—Myalgia—Gemcitabine—pancreatic cancer	0.000384	0.00285	CcSEcCtD
Amprenavir—Diabetes mellitus—Doxorubicin—pancreatic cancer	0.000382	0.00283	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000382	0.00283	CcSEcCtD
Amprenavir—Asthenia—Erlotinib—pancreatic cancer	0.00038	0.00282	CcSEcCtD
Amprenavir—Discomfort—Gemcitabine—pancreatic cancer	0.00038	0.00282	CcSEcCtD
Amprenavir—Pruritus—Tamoxifen—pancreatic cancer	0.000379	0.00281	CcSEcCtD
Amprenavir—Myalgia—Fluorouracil—pancreatic cancer	0.000378	0.0028	CcSEcCtD
Amprenavir—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000375	0.00279	CcSEcCtD
Amprenavir—Pruritus—Erlotinib—pancreatic cancer	0.000375	0.00278	CcSEcCtD
Amprenavir—Discomfort—Fluorouracil—pancreatic cancer	0.000373	0.00277	CcSEcCtD
Amprenavir—Nervous system disorder—Irinotecan—pancreatic cancer	0.000371	0.00275	CcSEcCtD
Amprenavir—Diarrhoea—Tamoxifen—pancreatic cancer	0.000367	0.00272	CcSEcCtD
Amprenavir—Abdominal pain—Sunitinib—pancreatic cancer	0.000363	0.00269	CcSEcCtD
Amprenavir—Diarrhoea—Erlotinib—pancreatic cancer	0.000363	0.00269	CcSEcCtD
Amprenavir—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000362	0.00268	CcSEcCtD
Amprenavir—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000361	0.00268	CcSEcCtD
Amprenavir—Anorexia—Irinotecan—pancreatic cancer	0.00036	0.00267	CcSEcCtD
Amprenavir—Skin disorder—Gemcitabine—pancreatic cancer	0.000358	0.00265	CcSEcCtD
Amprenavir—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000355	0.00264	CcSEcCtD
Amprenavir—Anorexia—Gemcitabine—pancreatic cancer	0.000351	0.00261	CcSEcCtD
Amprenavir—Erythema multiforme—Docetaxel—pancreatic cancer	0.000348	0.00258	CcSEcCtD
Amprenavir—Anorexia—Fluorouracil—pancreatic cancer	0.000345	0.00256	CcSEcCtD
Amprenavir—Cardiac disorder—Docetaxel—pancreatic cancer	0.000341	0.00253	CcSEcCtD
Amprenavir—Vomiting—Tamoxifen—pancreatic cancer	0.000341	0.00253	CcSEcCtD
Amprenavir—Paraesthesia—Irinotecan—pancreatic cancer	0.00034	0.00252	CcSEcCtD
Amprenavir—Rash—Tamoxifen—pancreatic cancer	0.000338	0.00251	CcSEcCtD
Amprenavir—Dermatitis—Tamoxifen—pancreatic cancer	0.000338	0.00251	CcSEcCtD
Amprenavir—Vomiting—Erlotinib—pancreatic cancer	0.000337	0.0025	CcSEcCtD
Amprenavir—Headache—Tamoxifen—pancreatic cancer	0.000336	0.00249	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000336	0.00249	CcSEcCtD
Amprenavir—Rash—Erlotinib—pancreatic cancer	0.000334	0.00248	CcSEcCtD
Amprenavir—Dermatitis—Erlotinib—pancreatic cancer	0.000334	0.00248	CcSEcCtD
Amprenavir—Headache—Erlotinib—pancreatic cancer	0.000332	0.00246	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000331	0.00246	CcSEcCtD
Amprenavir—Paraesthesia—Gemcitabine—pancreatic cancer	0.000331	0.00245	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00033	0.00245	CcSEcCtD
Amprenavir—Asthenia—Sunitinib—pancreatic cancer	0.000329	0.00244	CcSEcCtD
Amprenavir—Decreased appetite—Irinotecan—pancreatic cancer	0.000329	0.00244	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000326	0.00242	CcSEcCtD
Amprenavir—Fatigue—Irinotecan—pancreatic cancer	0.000326	0.00242	CcSEcCtD
Amprenavir—Paraesthesia—Fluorouracil—pancreatic cancer	0.000325	0.00241	CcSEcCtD
Amprenavir—Pruritus—Sunitinib—pancreatic cancer	0.000325	0.00241	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—pancreatic cancer	0.000323	0.0024	CcSEcCtD
Amprenavir—Mental disorder—Docetaxel—pancreatic cancer	0.000322	0.00239	CcSEcCtD
Amprenavir—Malnutrition—Docetaxel—pancreatic cancer	0.00032	0.00238	CcSEcCtD
Amprenavir—Decreased appetite—Gemcitabine—pancreatic cancer	0.00032	0.00238	CcSEcCtD
Amprenavir—Nausea—Tamoxifen—pancreatic cancer	0.000318	0.00236	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000318	0.00236	CcSEcCtD
Amprenavir—Fatigue—Gemcitabine—pancreatic cancer	0.000318	0.00236	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000316	0.00235	CcSEcCtD
Amprenavir—Nausea—Erlotinib—pancreatic cancer	0.000315	0.00234	CcSEcCtD
Amprenavir—Decreased appetite—Fluorouracil—pancreatic cancer	0.000315	0.00234	CcSEcCtD
Amprenavir—Diarrhoea—Sunitinib—pancreatic cancer	0.000314	0.00233	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000313	0.00232	CcSEcCtD
Amprenavir—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000309	0.00229	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000306	0.00227	CcSEcCtD
Amprenavir—Abdominal pain—Irinotecan—pancreatic cancer	0.000299	0.00222	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000299	0.00222	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000293	0.00217	CcSEcCtD
Amprenavir—Vomiting—Sunitinib—pancreatic cancer	0.000292	0.00217	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—pancreatic cancer	0.00029	0.00215	CcSEcCtD
Amprenavir—Rash—Sunitinib—pancreatic cancer	0.000289	0.00215	CcSEcCtD
Amprenavir—Dermatitis—Sunitinib—pancreatic cancer	0.000289	0.00215	CcSEcCtD
Amprenavir—Headache—Sunitinib—pancreatic cancer	0.000288	0.00213	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00028	0.00208	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000274	0.00203	CcSEcCtD
Amprenavir—Myalgia—Docetaxel—pancreatic cancer	0.000273	0.00202	CcSEcCtD
Amprenavir—Nausea—Sunitinib—pancreatic cancer	0.000273	0.00202	CcSEcCtD
Amprenavir—Asthenia—Irinotecan—pancreatic cancer	0.000271	0.00201	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000271	0.00201	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—pancreatic cancer	0.000268	0.00199	CcSEcCtD
Amprenavir—Asthenia—Gemcitabine—pancreatic cancer	0.000264	0.00196	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000261	0.00194	CcSEcCtD
Amprenavir—Pruritus—Gemcitabine—pancreatic cancer	0.000261	0.00193	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000259	0.00192	CcSEcCtD
Amprenavir—Diarrhoea—Irinotecan—pancreatic cancer	0.000259	0.00192	CcSEcCtD
Amprenavir—Nervous system disorder—Docetaxel—pancreatic cancer	0.000256	0.0019	CcSEcCtD
Amprenavir—Pruritus—Fluorouracil—pancreatic cancer	0.000256	0.0019	CcSEcCtD
Amprenavir—Skin disorder—Docetaxel—pancreatic cancer	0.000254	0.00188	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000254	0.00188	CcSEcCtD
Amprenavir—Diarrhoea—Gemcitabine—pancreatic cancer	0.000252	0.00187	CcSEcCtD
Amprenavir—Anorexia—Docetaxel—pancreatic cancer	0.000249	0.00185	CcSEcCtD
Amprenavir—Diarrhoea—Fluorouracil—pancreatic cancer	0.000248	0.00184	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000244	0.00181	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000242	0.00179	CcSEcCtD
Amprenavir—Vomiting—Irinotecan—pancreatic cancer	0.00024	0.00178	CcSEcCtD
Amprenavir—Rash—Irinotecan—pancreatic cancer	0.000238	0.00177	CcSEcCtD
Amprenavir—Dermatitis—Irinotecan—pancreatic cancer	0.000238	0.00177	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000238	0.00177	CcSEcCtD
Amprenavir—Headache—Irinotecan—pancreatic cancer	0.000237	0.00176	CcSEcCtD
Amprenavir—Paraesthesia—Docetaxel—pancreatic cancer	0.000235	0.00174	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—pancreatic cancer	0.000235	0.00174	CcSEcCtD
Amprenavir—Vomiting—Gemcitabine—pancreatic cancer	0.000234	0.00174	CcSEcCtD
Amprenavir—Rash—Gemcitabine—pancreatic cancer	0.000232	0.00172	CcSEcCtD
Amprenavir—Dermatitis—Gemcitabine—pancreatic cancer	0.000232	0.00172	CcSEcCtD
Amprenavir—Headache—Gemcitabine—pancreatic cancer	0.000231	0.00171	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—pancreatic cancer	0.00023	0.00171	CcSEcCtD
Amprenavir—Vomiting—Fluorouracil—pancreatic cancer	0.00023	0.00171	CcSEcCtD
Amprenavir—Rash—Fluorouracil—pancreatic cancer	0.000228	0.00169	CcSEcCtD
Amprenavir—Dermatitis—Fluorouracil—pancreatic cancer	0.000228	0.00169	CcSEcCtD
Amprenavir—Decreased appetite—Docetaxel—pancreatic cancer	0.000227	0.00169	CcSEcCtD
Amprenavir—Headache—Fluorouracil—pancreatic cancer	0.000227	0.00168	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000226	0.00167	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000226	0.00167	CcSEcCtD
Amprenavir—Fatigue—Docetaxel—pancreatic cancer	0.000225	0.00167	CcSEcCtD
Amprenavir—Nausea—Irinotecan—pancreatic cancer	0.000225	0.00167	CcSEcCtD
Amprenavir—Nausea—Gemcitabine—pancreatic cancer	0.000219	0.00162	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—pancreatic cancer	0.000217	0.00161	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000217	0.00161	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—pancreatic cancer	0.000216	0.0016	CcSEcCtD
Amprenavir—Nausea—Fluorouracil—pancreatic cancer	0.000215	0.0016	CcSEcCtD
Amprenavir—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000214	0.00159	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000213	0.00158	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—pancreatic cancer	0.000213	0.00158	CcSEcCtD
Amprenavir—Abdominal pain—Docetaxel—pancreatic cancer	0.000207	0.00153	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—pancreatic cancer	0.000201	0.00149	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—pancreatic cancer	0.0002	0.00148	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—pancreatic cancer	0.000197	0.00146	CcSEcCtD
Amprenavir—Asthenia—Docetaxel—pancreatic cancer	0.000188	0.00139	CcSEcCtD
Amprenavir—Pruritus—Docetaxel—pancreatic cancer	0.000185	0.00137	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—pancreatic cancer	0.000184	0.00136	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000183	0.00136	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—pancreatic cancer	0.000182	0.00135	CcSEcCtD
Amprenavir—Diarrhoea—Docetaxel—pancreatic cancer	0.000179	0.00133	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—pancreatic cancer	0.000173	0.00128	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—pancreatic cancer	0.000171	0.00127	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—pancreatic cancer	0.00017	0.00126	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000169	0.00125	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—pancreatic cancer	0.000168	0.00125	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—pancreatic cancer	0.000168	0.00125	CcSEcCtD
Amprenavir—Vomiting—Docetaxel—pancreatic cancer	0.000166	0.00123	CcSEcCtD
Amprenavir—Rash—Docetaxel—pancreatic cancer	0.000165	0.00122	CcSEcCtD
Amprenavir—Dermatitis—Docetaxel—pancreatic cancer	0.000165	0.00122	CcSEcCtD
Amprenavir—Headache—Docetaxel—pancreatic cancer	0.000164	0.00121	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000161	0.00119	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00016	0.00119	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—pancreatic cancer	0.000158	0.00118	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—pancreatic cancer	0.000158	0.00117	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—pancreatic cancer	0.000156	0.00115	CcSEcCtD
Amprenavir—Nausea—Docetaxel—pancreatic cancer	0.000155	0.00115	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—pancreatic cancer	0.000153	0.00114	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000152	0.00113	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—pancreatic cancer	0.000152	0.00113	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000149	0.0011	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—pancreatic cancer	0.000146	0.00109	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000144	0.00107	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—pancreatic cancer	0.000142	0.00105	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—pancreatic cancer	0.000141	0.00104	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—pancreatic cancer	0.000139	0.00103	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000133	0.00099	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—pancreatic cancer	0.000129	0.000957	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—pancreatic cancer	0.000127	0.000939	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—pancreatic cancer	0.000125	0.000926	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—pancreatic cancer	0.000121	0.000895	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—pancreatic cancer	0.000117	0.000868	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—pancreatic cancer	0.000115	0.000856	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—pancreatic cancer	0.000112	0.000832	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—pancreatic cancer	0.000112	0.000828	CcSEcCtD
Amprenavir—Rash—Epirubicin—pancreatic cancer	0.000111	0.000825	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—pancreatic cancer	0.000111	0.000824	CcSEcCtD
Amprenavir—Headache—Epirubicin—pancreatic cancer	0.00011	0.00082	CcSEcCtD
Amprenavir—Nausea—Epirubicin—pancreatic cancer	0.000105	0.000777	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—pancreatic cancer	0.000104	0.00077	CcSEcCtD
Amprenavir—Rash—Doxorubicin—pancreatic cancer	0.000103	0.000763	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—pancreatic cancer	0.000103	0.000762	CcSEcCtD
Amprenavir—Headache—Doxorubicin—pancreatic cancer	0.000102	0.000758	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—pancreatic cancer	9.69e-05	0.000719	CcSEcCtD
